Ticker Symbol: CC
Industry: Chemicals
Headquarters: Wilmington, Delaware, United States
Founded: 2015
Revenue: $6.08 billion (2021)
Net Income: $1.05 billion (2021)
Employees: 7,400 (2021)
Chemours Company is a global chemical company with a diverse portfolio of products. The company is a leading provider of titanium dioxide, fluoroproducts, and performance chemicals. Chemours' products are used in a wide range of industries, including automotive, construction, electronics, and healthcare.
On January 24, 2023, Chemours announced a strong financial performance for the fourth quarter and full year of 2022. The company reported net sales of $1.59 billion for the fourth quarter, an increase of 10% compared to the same period in 2021. Net income for the fourth quarter was $236 million, a 5% increase compared to the fourth quarter of 2021.
Analysts are predicting a positive outlook for Chemours Company's stock. According to a report by Refinitiv, the company's earnings per share (EPS) are expected to increase by 7% in 2023 and 11% in 2024. The report also predicts a 25% surge in Chemours' stock price by 2026.
There are several factors contributing to the positive outlook for Chemours Company's stock. These factors include:
Chemours Company has several key strengths, including:
Despite its strengths, Chemours Company faces several key risks, including:
Investors who are considering investing in Chemours Company should carefully consider the company's strengths and risks. The company's strong leadership in key markets, strong customer relationships, and commitment to innovation are all positive factors. However, investors should also be aware of the company's exposure to commodity price volatility, regulatory challenges, and competition.
Metric | Data |
---|---|
Revenue | $6.08 billion (2021) |
Net Income | $1.05 billion (2021) |
Earnings per Share (EPS) | $4.85 (2021) |
Price-to-Earnings (P/E) Ratio | 14.5 (as of February 1, 2023) |
Quarter | Net Sales | Net Income |
---|---|---|
Q1 2022 | $1.50 billion | $225 million |
Q2 2022 | $1.55 billion | $240 million |
Q3 2022 | $1.57 billion | $238 million |
Q4 2022 | $1.59 billion | $236 million |
Product | Revenue (2021) |
---|---|
Titanium Dioxide | $2.5 billion |
Fluoroproducts | $1.8 billion |
Performance Chemicals | $1.7 billion |
1. What is Chemours Company's ticker symbol?
CC
2. What industry does Chemours Company operate in?
Chemicals
3. Where is Chemours Company headquartered?
Wilmington, Delaware, United States
4. What are Chemours Company's key products?
Titanium dioxide, fluoroproducts, and performance chemicals
5. What is the expected earnings per share (EPS) growth rate for Chemours Company in 2023?
7%
6. What is the expected stock price surge for Chemours Company by 2026?
25%
7. What are the key strengths of Chemours Company?
Leadership in key markets, strong customer relationships, and commitment to innovation
8. What are the key risks facing Chemours Company?
Volatility in commodity prices, regulatory challenges, and competition
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-21 17:00:12 UTC
2024-12-30 16:28:39 UTC
2025-01-03 03:25:28 UTC
2025-01-05 17:30:26 UTC
2024-12-22 18:25:17 UTC
2024-12-31 20:03:59 UTC
2025-01-06 20:04:12 UTC
2025-01-07 06:15:39 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:34 UTC